 With Israel s Fast-Paced E-Commerce Adoption and Cannabis Markets High Growth Rate Averaging 4 Percent 1 per Month, Panaxias Online Platform to Support Patient Base Expansion Acquisition Broadens IMCs Patient Offering in Israel, Facilitates Stronger Direct Patient Relationships and Enables the Company to Grow its IMC Brand Awareness Offers Additional Opportunity to Generate Revenue and Margin on Third-Party Products and is Synergistic with IMCs Premium and Super-Premium Canadian Indoor Production Portfolio Adds Key Storage, Distribution and Delivery Capabilities, Plus Established Call Center to Support Growth as Israeli Market Prepares for Potential Adult-Use Recreational Cannabis Legalization TORONTO, ON GLIL YAM and LOD, ISRAEL April 30, 2021 IM Cannabis Corp. IMC or the Company CSE:IMCCNASDAQ:IMCC, a multi-country operator MCO in the medical and adult-use recreational cannabis sectors with operations in Israel, Germany and Canada, announced today that its fully owned Israeli subsidiary, IMC Holdings Ltd., along with Panaxia Pharmaceutical Industries Israel Ltd. 